Shanghai Rendu Biotechnology
Latest round
- Series C
Last raised
- Aug 2018
Total raised
- $15M
Investors
- 3
About Shanghai Rendu Biotechnology
Founded in 2007 and based in Shanghai, China, Shanghai Rendu Biotechnology operates as a biotechnology company that foucses on RNA molecular diagnostic technology. Chinese Journal of Antituberculosis has become the strategic partner of the company in June 2021. The company awarded as "2020 China Medical Device Technology Innovation Enterprise" in October 2021. The company provides RNA molecular diagnostic products for many fields such as clinical testing, blood screening, food safety testing and infectious diseases. The company's develops simultaneous amplification technology and testing (SAT) technology platform and specific target capture. The company's products include reproductive health, respiratory diseases and enterovirus products. Reproductive health products include chlamydia trachomatis, neisseria gonorrhoeae and mycoplasma genitalium nucleic acid detection kit. Respiratory diseases products include novel coronavirus 2019-nCoV, universal influenza A virus and mycoplasma pneumoniae nucleic acid detection kit.
Who invested in Shanghai Rendu Biotechnology
3 investors across 3 rounds
See all investors in Shanghai Rendu Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Rendu Biotechnology
Who invested in Shanghai Rendu Biotechnology?
Shanghai Rendu Biotechnology has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Rendu Biotechnology raised?
Shanghai Rendu Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Rendu Biotechnology last raise money?
Shanghai Rendu Biotechnology's most recent round on record is a Series C, in Aug 2018.
What does Shanghai Rendu Biotechnology do?
Founded in 2007 and based in Shanghai, China, Shanghai Rendu Biotechnology operates as a biotechnology company that foucses on RNA molecular diagnostic technology.
Where is Shanghai Rendu Biotechnology headquartered?
Shanghai Rendu Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Rendu Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Rendu Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Shanghai Rendu Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.